LU80016A1 - Procede de preparation de nouvelles 4-pyrones substituees en positions 2,3 et 6 et medicament les contenant - Google Patents

Procede de preparation de nouvelles 4-pyrones substituees en positions 2,3 et 6 et medicament les contenant Download PDF

Info

Publication number
LU80016A1
LU80016A1 LU80016A LU80016A LU80016A1 LU 80016 A1 LU80016 A1 LU 80016A1 LU 80016 A LU80016 A LU 80016A LU 80016 A LU80016 A LU 80016A LU 80016 A1 LU80016 A1 LU 80016A1
Authority
LU
Luxembourg
Prior art keywords
group
methyl
chosen
formula
hydrogen atom
Prior art date
Application number
LU80016A
Other languages
English (en)
French (fr)
Inventor
J Plattner
D Kuhla
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU80016A1 publication Critical patent/LU80016A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU80016A 1977-07-22 1978-07-21 Procede de preparation de nouvelles 4-pyrones substituees en positions 2,3 et 6 et medicament les contenant LU80016A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81804377 1977-07-22
US05/818,043 US4132847A (en) 1977-07-22 1977-07-22 4-Pyrone prostaglandin antagonists

Publications (1)

Publication Number Publication Date
LU80016A1 true LU80016A1 (fr) 1980-02-14

Family

ID=25224503

Family Applications (1)

Application Number Title Priority Date Filing Date
LU80016A LU80016A1 (fr) 1977-07-22 1978-07-21 Procede de preparation de nouvelles 4-pyrones substituees en positions 2,3 et 6 et medicament les contenant

Country Status (11)

Country Link
US (1) US4132847A (ja)
JP (3) JPS5814435B2 (ja)
BE (1) BE869166A (ja)
DE (1) DE2831761C2 (ja)
DK (1) DK148538C (ja)
FR (2) FR2398067A1 (ja)
GB (2) GB2001639B (ja)
IE (1) IE47035B1 (ja)
IT (1) IT1099579B (ja)
LU (1) LU80016A1 (ja)
NL (1) NL173750C (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0138523Y2 (ja) * 1981-01-31 1989-11-17
JPS5834046U (ja) * 1981-08-31 1983-03-05 株式会社明電舎 溶存酸素計
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
CA2113787A1 (en) * 1993-01-29 1994-07-30 Nobuyuki Hamanaka Carbocyclic sulfonamides
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6037368A (en) * 1997-05-09 2000-03-14 Mount Sinai School Of Medicine 8-iso- prostaglandins for glaucoma therapy
US20020115695A1 (en) * 2000-11-07 2002-08-22 Paralkar Vishwas M. Combination therapies for the stimulation of bone growth
US20030220377A1 (en) * 2002-05-08 2003-11-27 Richard Chesworth Indole compounds and their use as estrogen agonists/antagonists
US20040002524A1 (en) * 2002-06-24 2004-01-01 Richard Chesworth Benzimidazole compounds and their use as estrogen agonists/antagonists
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
CA2677769C (en) 2007-02-16 2016-01-19 Ono Pharmaceutical Co., Ltd. Therapeutic agent for urinary excretion disorder
CA3090807A1 (en) 2018-02-21 2019-08-29 AI Therapeutics, Inc. Combination therapy with apilimod and glutamatergic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468916A (en) * 1966-11-01 1969-09-23 Pfizer & Co C 2-vinylpyromeconic acid

Also Published As

Publication number Publication date
FR2398067B1 (ja) 1980-06-06
DE2831761A1 (de) 1979-01-25
NL173750C (nl) 1984-03-01
GB2001639A (en) 1979-02-07
FR2398067A1 (fr) 1979-02-16
FR2401147B1 (ja) 1981-08-28
FR2401147A1 (fr) 1979-03-23
GB2001639B (en) 1982-03-17
IE781471L (en) 1979-01-22
JPS5814435B2 (ja) 1983-03-18
NL7807803A (nl) 1979-01-24
JPS5730110B2 (ja) 1982-06-26
GB2055375A (en) 1981-03-04
JPS5730109B2 (ja) 1982-06-26
IT7825999A0 (it) 1978-07-21
NL173750B (nl) 1983-10-03
DE2831761C2 (de) 1984-12-13
IE47035B1 (en) 1983-11-30
DK326378A (da) 1979-01-23
IT1099579B (it) 1985-09-18
JPS5424876A (en) 1979-02-24
DK148538B (da) 1985-07-29
DK148538C (da) 1986-01-13
JPS54160382A (en) 1979-12-19
US4132847A (en) 1979-01-02
JPS54160383A (en) 1979-12-19
BE869166A (fr) 1979-01-22
GB2055375B (en) 1982-08-11

Similar Documents

Publication Publication Date Title
EP0061386B1 (fr) Acides ((2-oxo-3-tétrahydrothiénylcarbamoyl)-alkylthio) acétiques, leurs sels et leurs esters, leur procédé de préparation et les compositions pharmaceutiques en contenant
LU80016A1 (fr) Procede de preparation de nouvelles 4-pyrones substituees en positions 2,3 et 6 et medicament les contenant
EP0013960B1 (de) Substituierte Acetophenone, diese enthaltende Präparate und Verfahren zu deren Herstellung
EP0051917B1 (en) Benzofuran ethanolamine derivatives, processes for their preparation, and their use in medicine
EP0202759B1 (en) Leukotriene antagonists
US4829081A (en) Analogs of mevalonolactone and derivatives thereof
CH619691A5 (ja)
US4219483A (en) 4-Pyrone prostaglandin antagonists
EP0256936A1 (fr) Nouveaux dérivés de la benzyl-4 pipérazine, leur préparation et les compositions pharmaceutiques qui les contiennent
CH624934A5 (ja)
HU211554A9 (en) Circulation-active dibenzo/1,5/dioxocin-5-ones
FR2568248A1 (fr) Nouveaux composes naphtaleniques, leur preparation et leur application comme medicaments
FR2492378A1 (fr) Derives de type 6h-dibenzo(b,d) pyranne 6-substitues utiles notamment comme medicaments antiulcereux, immunomodulateurs et antiviraux et procedes de leur preparation
US4772625A (en) 1,3-dioxan-5-yl-hexenoic acids
US4775684A (en) 1,3-dioxane ethers
EP0071175B1 (de) Phenylalkyloxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
DE2737807A1 (de) C tief 1 -p-biphenylester von omega-pentanorprostaglandinen
DE2709347A1 (de) Erythro-15,16-dioxyprostensaeuren und -ester sowie verfahren zu ihrer herstellung
FR2488604A1 (fr) Derives d'heteroprostaglandines ainsi que leurs procedes de preparation
LU79801A1 (fr) Procede de preparation de nouveaux derives substitues en position 15 d'w-pentanorprostaglandine
EP0049144B1 (en) 5-fluoro uracil derivatives
FR2510567A1 (fr) Isomere optique du 11a, 15-dihydroxy 16-methoxy-16-methyl-prosta 13 (e)-ene-1-oate de methyle, utile notamment comme agent gastroprotecteur et son procede de preparation
CH648483A5 (fr) Composition pharmaceutique contre l'arthrite rhumatoide.
FR2507603A1 (fr) 1, 2, 3, 4, 4a, 9b-hexahydro-4a-piperazinylmethyl-4-dibenzofuranones ou 4-dibenzofuranols substitues, procede de synthese et application en therapeutique
WO2001038310A1 (fr) Derives de 2-arylquinoleine, leur preparation et leur application en therapeutique